A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

In June 2025, Carmot Therapeutics Inc. announced a Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of ...

The launch of the FIBRE Consortium, which includes Lantheus Holdings (NasdaqGM:LNTH) collaborating with Pfizer and Lumina Pharmaceuticals, aims to improve treatment for fibrotic diseases using ...

The recent formation of the FIBRE Consortium, a collaboration involving Pfizer (NYSE:PFE) and other pharmaceutical partners, ...

The Prostate Cancer Market is set to grow from USD 11.7 Billion in 2022 to USD 21.6 Billion by 2031, driven by rising cases in targeted therapies. The U.S. Prostate Cancer Market is expanding rapidly ...

Currently, Alphamab trades at a price-to-earnings (P/E) ratio of 44 times, even higher than the 30 times for Henlius Biotech ...

Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

During a live event, Neal E. Ready, MD, and participants discussed use of PD-L1 status in non–small cell lung cancer and ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to ...

Many established medical therapies to treat myasthenia gravis remain in use, and newer options are available for patients who ...

It is hard to think of a less coherent pair of policies: President Trump’s tax policy encourages the very offshoring that his ...

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including ANI ...